Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Three CHMP Negative Opinions ‒ But Who Got A Boon?

Executive Summary

The European Medicines Agency's advisory committee, the CHMP, unusually issued three negative opinions at its recent monthly meeting. Which companies received an unexpected boon at the news?

Advertisement

Related Content

New Treatments For Psoriasis, Ovarian Cancer And MS Seeking CHMP Thumbs Up This Week
Rydapt set for EU approval after Novartis addresses CHMP concerns
EU CHMP Decides On New Oncology Drugs & New Treatments for Mastocytosis, Atopic Dermatitis
Pulled From EU Assessment Process: Orphan Drugs For Kidney Disease, Mesothelioma
Imminent EU CHMP Opinions: Kidney And Breast Cancer, Mastocytosis, MS, Emphysema & Hepatitis C
XBiotech Faces Uphill Task With Xilonix
Keytruda Approval Opens New Routes For Immuno-Oncology
Novartis Takes Aim At Systemic Mastocytosis With Midostaurin

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC098811

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel